Filtros de búsqueda

Lista de obras de Antonio Bertolotto

5D4 keratan sulfate epitope identifies a subset of ramified microglia in normal central nervous system parenchyma.

artículo científico publicado en 1998

A Comprehensive Review on Copemyl(®).

artículo científico publicado en 2017

A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients.

artículo científico publicado en 2009

A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients

artículo científico publicado en 2016

A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis

artículo científico publicado en 2008

A methodological reappraisal of non invasive high voltage electrical stimulation of lumbosacral nerve roots

artículo científico publicado en 2011

A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™-the FUTURE study.

artículo científico

A new neurophysiological approach to assess central motor conduction damage to proximal and distal muscles of lower limbs

artículo científico publicado en 2013

A20 in Multiple Sclerosis and Parkinson's Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways?

artículo científico publicado en 2017

Acute confusional state in HaNDL syndrome (transient headache and neurologic deficits with cerebrospinal fluid lymphocytosis)

artículo científico publicado en 2014

Acute muscle necrosis after chronic overdosage of phenformin and fenfluramine

artículo científico publicado en 1978

Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosis.

artículo científico publicado en 2008

Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.

artículo científico publicado en 2016

Anal sphincter dysfunction in multiple sclerosis: an observation manometric study.

artículo científico publicado en 2016

Anti-inflammatory genes associated with multiple sclerosis: a gene expression study.

artículo científico publicado en 2015

Anti-interferon-beta neutralising activity is not entirely mediated by antibodies

scientific article published on 22 October 2007

Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study

artículo científico publicado en 2016

Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study

artículo científico publicado en 2002

Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience

article

Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment

scientific article published on 21 October 2020

Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10years in responder multiple sclerosis patients

artículo científico publicado en 2017

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies.

artículo científico publicado en 2004

Biological monitoring of IFN-β therapy in Multiple Sclerosis.

artículo científico publicado en 2014

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis.

artículo científico publicado en 2005

Biopharmaceuticals: Reference Products and Biosimilars to Treat Inflammatory Diseases.

artículo científico publicado en 2017

CD19 mRNA quantification improves rituximab treatment-to-target approach: a proof of concept study

artículo científico publicado en 2014

Cerebrospinal fluid analysis and the determination of oligoclonal bands.

artículo científico publicado en 2017

Chondroitin 4-sulfate proteoglycan forms an extracellular network in human and rat central nervous system

artículo científico publicado en 1990

Chondroitin sulfate proteoglycan surrounds a subset of human and rat CNS neurons.

artículo científico publicado en 1991

Chondroitin, chondroitin 6-sulphate, chondroitin 4-sulphate and dermatan sulphate proteoglycans in normal and pathological human muscle

article

Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-γ and interleukin-4 response.

artículo científico publicado en 2012

Cognitive impairment and structural brain damage in benign multiple sclerosis.

artículo científico publicado en 2008

Collagenase in the immunohistochemical demonstration of laminin, fibronectin and factor VIII/RAg in nervous tissue after fixation.

artículo científico publicado en 1984

Computerized posturography is more sensitive than clinical Romberg Test in detecting postural control impairment in minimally impaired Multiple Sclerosis patients

artículo científico publicado en 2017

Congenital muscular dystrophy associated with familial junctional epidermolysis bullosa letalis

artículo científico publicado en 1993

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis

artículo científico publicado en 2013

Corpus callosum damage and cognitive dysfunction in benign MS.

artículo científico publicado en 2009

Correction to: Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach

artículo científico publicado en 2017

Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients

artículo científico publicado en 2016

Decline of Neuropsychological Abilities in a Large Sample of Patients with Multiple Sclerosis: A Two-Year Longitudinal Study.

artículo científico publicado en 2016

Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients.

artículo científico publicado en 2017

Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory

artículo científico publicado en 2016

Development of a bioassay for quantification of neutralising antibodies against human interferon-beta in mouse sera.

artículo científico publicado en 2008

Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD).

artículo científico publicado en 2017

Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory.

artículo científico publicado en 2002

Disappearance of the Vicia villosa-positivity from the perineuronal net containing chondroitin proteoglycan after chondroitinase digestion

artículo científico publicado en 1995

Drug Efficacy Monitoring in Pharmacotherapy of Multiple Sclerosis With Biological Agents

artículo científico publicado en 2017

Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.

artículo científico publicado en 2013

Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice

artículo científico publicado en 2014

Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial

artículo científico publicado en 2012

Epidemiology of Duchenne muscular dystrophy in the province of Turin

scientific article published on 01 January 1981

Erratum to: Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients

scientific article published on 01 February 2017

Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group

article

Evaluation of IFNalpha bioavailability by MxA mRNA in HCV patients.

artículo científico publicado en 2002

Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology

artículo científico publicado en 2012

Evaluation of bioavailability of three types of IFNbeta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification.

artículo científico publicado en 2001

Evaluation of the impact of neutralizing antibodies on IFNβ response.

artículo científico

Expression and regulation of IFNalpha/beta receptor in IFNbeta-treated patients with multiple sclerosis.

artículo científico publicado en 2008

Fate of multiple sclerosis patients positive for neutralising antibodies towards interferon beta shifted to alternative treatments

scientific article published on 01 December 2005

Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis

artículo científico publicado en 2015

Glutamate dehydrogenase (GDH) deficiency in different types of progressive hereditary cerebellar ataxia

artículo científico publicado en 1988

Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years.

artículo científico publicado en 2006

Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders

artículo científico publicado en 2014

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.

artículo científico

High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study

artículo científico publicado en 2016

High-dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption

artículo científico publicado en 2006

Histochemical and Ultrastructural Findings in a Case of Centronuclear Myopathy ⬇️

artículo científico publicado el 1 de enero de 1978

Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis

artículo científico publicado en 2015

Immunohistochemical mapping of perineuronal nets containing chondroitin unsulfated proteoglycan in the rat central nervous system.

artículo científico publicado en 1996

Implications of neutralising antibodies on therapeutic efficacy.

artículo científico publicado en 2009

In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.

artículo científico publicado en 2007

In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis ⬇️

artículo científico publicado el 1 de diciembre de 2001

In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.

artículo científico publicado en 2009

Ineffectiveness of allopurinol in Duchenne muscular dystrophy

Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis

scientific article published on 01 December 2005

Interferon beta neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations

scientific article published on 01 July 2000

Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.

artículo científico publicado en 2007

Is serum neopterin level a marker of responsiveness to interferon beta-1a therapy in multiple sclerosis?

artículo científico publicado en 2004

Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology

artículo científico publicado en 2013

Keratan sulphate is a marker of differentiation of ramified microglia

artículo científico publicado en 1995

Laminin and fibronectin distribution in normal and pathological human muscle

artículo científico publicado en 1983

Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis

artículo científico publicado en 2010

Long-term disability progression in primary progressive multiple sclerosis: a 15-year study

artículo científico publicado en 2017

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.

artículo científico publicado en 2018

Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach

artículo científico publicado en 2017

Measurement of neutralizing antibodies to interferon beta in patients with multiple sclerosis.

artículo científico publicado en 2004

Mitochondrial abnormalities of late motor neuron degeneration following poliomyelitis and other neurogenic muscular atrophies ⬇️

artículo científico publicado el 1 de septiembre de 1979

Monoclonal antibodies to keratan sulfate immunolocalize ramified microglia in paraffin and cryostat sections of rat brain.

artículo científico publicado en 1993

Monocytes and CD4+ T cells contribution to the under-expression of NR4A2 and TNFAIP3 genes in patients with multiple sclerosis

article

Morphological and biochemical investigations of mitral valve endocardiosis in pigs

scientific article published on 01 March 1997

Motor neuron disease following poliomyelitis. Bioptic study of five cases

scientific article published on 01 January 1980

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica

artículo científico publicado en 2016

NURR1 Impairment in Multiple Sclerosis

artículo científico publicado en 2019

NURR1 deficiency is associated to ADHD-like phenotypes in mice

scientific article published on 27 August 2019

Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers.

artículo científico publicado en 2015

Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.

artículo científico publicado en 2015

Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation.

artículo científico publicado en 2011

Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group—Italian Neurological Society

article

Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.

artículo científico publicado en 2015

Necrotizing skin lesions and NABs development in a multiple sclerosis patient treated with IFNbeta 1b

artículo científico publicado en 2003

Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse

artículo científico publicado en 2003

Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report

artículo científico publicado en 2007

Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs.

artículo científico publicado en 2003

Neutralizing antibodies to interferon beta: implications for the management of multiple sclerosis.

artículo científico publicado en 2004

No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab discontinuation

artículo científico publicado en 2014

Normative Values for Intertrial Variability of Motor Responses to Nerve Root and Transcranial Stimulation: A Condition for Follow-Up Studies in Individual Subjects

artículo científico publicado en 2016

Nurr1 reduction influences the onset of chronic EAE in mice.

artículo científico publicado en 2015

One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients.

artículo científico publicado en 2010

PML risk stratification using anti-JCV antibody index and L-selectin.

artículo científico publicado en 2015

Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-α Therapy

artículo científico publicado en 2015

Predictive markers for response to interferon therapy in patients with multiple sclerosis

artículo científico publicado en 2008

Presence and Significant Determinants of Cognitive Impairment in a Large Sample of Patients with Multiple Sclerosis ⬇️

artículo científico publicado el 29 de julio de 2013

Prevalence and Significant Determinants of Post-traumatic Stress Disorder in a Large Sample of Patients with Multiple Sclerosis ⬇️

artículo científico publicado el 1 de junio de 2013

Prevalence of Posttraumatic Stress Disorder in Patients With Multiple Sclerosis.

artículo científico publicado en 2018

Progressive multifocal leukoencephalopathy in Good's syndrome

artículo científico publicado en 2010

Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years

artículo científico publicado en 2020

Qualitative and quantitative analysis of antibody response against IFNbeta in patients with multiple sclerosis.

artículo científico publicado en 2006

Quality of life and patient preferences: identification of subgroups of multiple sclerosis patients.

artículo científico publicado en 2015

Quantitative PCR reveals increased levels of tumor necrosis factor-alpha mRNA in peripheral blood mononuclear cells of multiple sclerosis patients during relapses.

artículo científico publicado en 1999

Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases

artículo científico publicado en 2017

Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

artículo científico publicado en 2007

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

artículo científico publicado en 2010

Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group.

artículo científico publicado en 2011

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

artículo científico publicado en 2012

Reversible disconnection syndrome in a case of acute tumefactive demyelinating lesion: a PET study

artículo científico publicado en 2016

Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab

artículo científico publicado en 2012

Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

artículo científico publicado en 2017

Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI.

artículo científico publicado en 2004

Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod

artículo científico publicado en 2018

TNFAIP3 Deficiency Affects Monocytes, Monocytes-Derived Cells and Microglia in Mice

artículo científico publicado en 2020

The Effectiveness of a Body-Affective Mindfulness Intervention for Multiple Sclerosis Patients with Depressive Symptoms: A Randomized Controlled Clinical Trial.

artículo científico publicado en 2017

The Footprints of Poly-Autoimmunity: Evidence for Common Biological Factors Involved in Multiple Sclerosis and Hashimoto's Thyroiditis.

artículo científico publicado en 2018

The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial

artículo científico publicado en 2016

The heritage of glatiramer acetate and its use in multiple sclerosis

article by Giancarlo Comi et al published 4 July 2016 in Multiple Sclerosis and Demyelinating Disorders

The pharmacovigilance program on natalizumab in Italy: 2 years of experience

artículo científico publicado en 2009

The transcription factor Nurr1 is up-regulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice

scientific article published on 18 March 2020

The use of the 25 Sprotte needle markedly reduces post-dural puncture headache in routine neurological practice

artículo científico publicado en 2015

Three years of experience: the Italian registry and safety data update.

artículo científico publicado en 2011

Two-dimensional immunoelectrophyoresis of unconcentrated cerebrospinal fluid ⬇️

artículo científico publicado el 1 de julio de 1978

Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification

scientific article published on 16 May 2012

Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease)

article

Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis

artículo científico publicado en 2015

Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica

artículo científico publicado en 2009

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda